Quatera 700 vs. Centurion
NCT: NCT06225362 · COMPLETED
Brief Summary
Phacoemulsification is the most common treatment for cataract surgery in the developed countries and over the years it gained importance due to several factors: small incision, surgery performed under topical anesthesia - which reduce injection-related complications - short recovery time, low post operatory induced astigmatism, and low incidence of surgical complications, when compared to the conventional surgeries. The study evaluates 2 different phacoemulsification devices in patients undergoing routine cataract surgery in both eyes.
Frequently Asked Questions
What is Quatera 700 vs. Centurion?
Quatera 700 vs. Centurion is a clinical trial registered under NCT06225362. Current status: COMPLETED.
What is the status of NCT06225362?
The current status of NCT06225362 (Quatera 700 vs. Centurion) is: COMPLETED.
When did Quatera 700 vs. Centurion start?
Quatera 700 vs. Centurion started on 2024-01-10.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.